Mammendorfer Institut für Physik und Medizin

What Mammendorfer Institut für Physik und Medizin does

MIPM Mammendorfer Institut für Physik und Medizin GmbH is a German family-owned medical device company founded in 1982 and headquartered in Mammendorf, Upper Bavaria. The company specializes in developing and manufacturing equipment that reliably measures and displays vital parameters — blood pressure, ECG, oxygen saturation, neuromuscular blockade, and related signals — inside the extreme electromagnetic environment of an MRI scanner, where conventional medical monitors fail or become unsafe. All products are developed and manufactured in Germany under DIN EN ISO 13485, MDSAP, and EU MDR (2017/745) certifications.

The product portfolio spans the Tesla line of MRI-compatible multiparameter patient monitors (Tesla DUO combining pulse oximetry and non-invasive blood pressure, Tesla M3 with full vital signs monitoring plus a veterinary variant, and the forthcoming Tesla SX1 combined defibrillator/patient monitor), the Tesla iV1 MRI-compatible infusion system built on the B. Braun Spaceplus platform, and the TOF3D neuromuscular blockade monitor that uniquely combines acceleromyography (AMG) and mechanomyography (MMG) in a single handheld device. MIPM also offers contract development services to other medical device manufacturers — including Fresenius Kabi, B. Braun, Getinge, MSD, and Klinikum Fürstenfeldbruck — taking MRI-compatible devices from concept through CE marking, FDA 510(k), and other international approvals.

MIPM distributes finished devices exclusively through a trained global network of authorized dealers spanning roughly 70 countries, supplemented by a wholly-owned US subsidiary (MIPM US INC., Montgomery, TX), and reports an export share exceeding 80%. The company is led by Managing Director Jennifer Rosenheimer (the second-generation family owner who took over in October 2019), with President Michael N. Rosenheimer as sole shareholder, and an expanded management board effective January 2026 that adds Head of Product Development Andreas Klement.

Name

Mammendorfer Institut für Physik und Medizin

Legal name

MIPM Mammendorfer Institut für Physik und Medizin GmbH

Website

https://mipm.com

Company type

Private

Founded year

1982

Operating status

Operating

Headcount range

51–100 employees

Short description

MIPM is a German family-owned medical device company that develops and manufactures MRI-compatible patient monitors, defibrillators, infusion systems, and neuromuscular monitors for hospitals, imaging centers, and veterinary MRI practices worldwide, distributed through a global dealer network.

Ownership category

akta.pro rank

Product category

MRI-Compatible Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

akta.pro secondary industry

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)

Keywords

• MRI-compatible patient monitoring
• Medical device manufacturing
• MRI defibrillator equipment
• Neuromuscular blockade monitors
• MRI infusion systems

Headquarters

HQ city

Mammendorf

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. MRI-Compatible Medical Device Sales: MIPM develops and manufactures MRI-compatible patient monitors (Tesla DUO, Tesla M3), defibrillators (Tesla SX1), infusion systems (Tesla iV1), and neuromuscular monitors (TOF3D), sold as finished medical devices through its global dealer network. Revenue is generated through product sales to hospitals, clinics, and veterinary practices worldwide.
2. Contract Development / OEM Services: MIPM offers contract development services to other medical device manufacturers, developing MRI-compatible devices and components to order. The company works with customers through five stages from concept to series production, including regulatory support (CE, FDA 510(k), international approvals). Reference customers include Fresenius Kabi, B. Braun, Getinge, MSD, and Klinikum Fürstenfeldbruck. This is a professional services and potentially licensing/royalties revenue stream.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

MIPM develops, manufactures, and distributes MRI-compatible medical devices that measure and display vital parameters (blood pressure, ECG, oxygen saturation, neuromuscular blockade) safely inside the magnetic resonance imaging environment. The product portfolio includes MRI-compatible patient monitors (Tesla DUO, Tesla M3, Tesla M3 vet), an MRI defibrillator with integrated monitoring (Tesla SX1), an MRI-compatible infusion system rack (Tesla iV1), and a Train-of-Four neuromuscular monitor (TOF3D). The company also provides contract development and manufacturing services to other medical device manufacturers under ISO 13485 and EU MDR.

Product overview

MIPM develops and manufactures a portfolio of MRI-compatible medical devices centered on patient monitoring and neuromuscular assessment. The core portfolio includes the Tesla DUO (combined pulse oximeter and blood pressure monitor), the Tesla M3 (multiparameter patient monitor also available in a veterinary variant Tesla M3 vet), and the Tesla SX1 (defibrillator combined with patient monitor, in development). These are complemented by the Tesla iV1 infusion system, which is built on the B. Braun Spaceplus platform and provides MRI-compatible infusion delivery. A second product line is the TOF3D neuromuscular blockade monitor, which supports both Acceleromyography (AMG) and Mechanomyography (MMG) for Train-of-Four monitoring in the OR and ICU. The company also offers contract development services for custom MRI-compatible medical devices. All products are developed and manufactured exclusively in Germany under ISO 13485 and MDR quality standards.

Differentiator

Problem solved

Functional benefit

Brands

• Tesla Product Line: MRI-compatible patient monitoring systems including TeslaDUO (pulse oximeter and blood pressure monitor), TeslaM3 (multi-parameter patient monitor), Tesla SX1 (MRI defibrillator and patient monitor), and Tesla iV1 (MRI system rack for infusion pumps).
• TOF Product Line

Products and services

• Tesla DUO MRI-compatible combined pulse oximeter and non-invasive blood pressure monitor for patients undergoing MRI examinations. Measures and displays vital parameters including oxygen saturation and blood pressure under the extreme conditions of a magnetic resonance scanner.
• Tesla M3 MRI-compatible multiparameter patient monitoring system that reliably measures and displays vital parameters (blood pressure, ECG, oxygen saturation, and more) under the extreme conditions of an MRI scanner. Functions as the central monitoring hub in the MRI environment.
• Tesla SX1 MRI-compatible defibrillator combined with patient monitor providing basic patient monitoring via wireless OMNI Sense SpO2/ECG sensor and defibrillation/cardioversion capability in one compact solution designed to remain inside the MRI cabin during examinations.
• Tesla iV1 MRI-compatible single-channel infusion system based on the B. Braun Spaceplus Infusion Pump. Can be equipped with a syringe pump or volumetric pump, used as a standalone system or mounted on the TeslaiV1 Trolley. Provides controlled infusion delivery within the MRI environment.
• Tesla M3 vet Veterinary version of the Tesla M3 MRI-compatible patient monitoring system, designed for use during MRI examinations of animals in veterinary clinics and animal hospitals.
• TOF3D Neuromuscular blockade monitor (Train-of-Four monitor) combining Acceleromyography (AMG) and Mechanomyography (MMG) measurement in one handheld device. Features multiple stimulation modes, 4.4-inch LCD display, battery operation exceeding 1,500 hours, and integrated trend memory with data download capability. Used in the OR or intensive care unit.
• Contract Development Services Contract development and manufacturing of MRI-compatible medical devices under DIN EN ISO 13485 and EU MDR, supporting customers through five stages from concept to series production, including regulatory support (CE, FDA 510(k), and international approvals). Reference customers include Fresenius Kabi, B. Braun, Getinge, MSD, and Klinikum Fürstenfeldbruck.

Quantifiable outcome

• Export share exceeds 80 percent — demonstrating strong international market penetration for a mid-sized German medical technology company.
• +1 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Partnerships

One partnership is on record.

• B. BrauncoreTechnology or IntegrationB. Braun's Space plus infusion pump serves as the hardware platform for the Tesla iV1 MRI-compatible infusion system. MIPM integrates its MRI expertise with B. Braun's proven infusion pump technology to create a product that combines B. Braun's core device with MRI-compatible system rack and accessories designed by MIPM.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• Nonin Medical: Nonin specializes in pulse oximetry and capnography, including MRI-conditional SpO2 sensors. It is a niche but direct competitor in the MRI-compatible pulse oximetry segment where MIPM's Tesla DUO has historically competed.
• Masimo: Masimo is a leader in pulse oximetry and advanced patient monitoring, increasingly active in MRI-conditional SpO2 monitoring. It competes with the SpO2 functionality of MIPM's Tesla DUO and M3, particularly in the US where Masimo's hospital installed base is strong.

Broad incumbents

• Mindray: Mindray is a large global patient monitoring vendor rapidly expanding in Europe and emerging markets, with MRI-compatible monitoring options. Its scale and aggressive pricing put pressure on specialist MRI vendors in mid-tier hospital segments where MIPM's Tesla M3 competes.
• Philips Healthcare: Philips offers MRI scanners themselves as well as broader patient monitoring solutions used inside and adjacent to the MRI suite. As a vertically integrated imaging and monitoring player, Philips can bundle MRI-compatible monitoring into enterprise deals that are difficult for a specialist like MIPM to win.
• GE HealthCare: GE HealthCare manufactures MRI systems and sells patient monitoring solutions with MRI-conditional variants. Its installed base of MRI scanners and integrated monitoring portfolio make it a direct competitive threat whenever hospitals standardize on a single imaging/monitoring vendor.
• Drägerwerk: Dräger is a major patient monitoring and anesthesia vendor with MRI-conditional monitoring options and a much larger installed base in hospitals globally. It competes with MIPM at the high-acuity monitoring end and benefits from broader hospital contracts that can displace specialist vendors.

Others

• Fresenius Kabi: Fresenius Kabi is a contract development customer of MIPM and a major infusion and clinical nutrition device vendor. The relationship is both a validation of MIPM's MRI-compatibility expertise and an indicator of the broader infusion/pump market in which MIPM's iV1 participates.
• B. Braun: B. Braun is both a partner (the Spaceplus platform underpins the Tesla iV1) and an adjacent medtech player with its own infusion and monitoring portfolio. It is comparable to MIPM as a relationship counterparty in the MRI infusion space and represents both collaboration and channel overlap.

Direct peers

• IRadimed Corporation: IRadimed is the most direct peer, developing MRI-compatible IV infusion pumps and patient vital signs monitoring devices (including the MRidium 3860+ and the iVAS MRI-compatible vital signs monitor). It serves the same hospitals, radiology departments, and anesthesia teams as MIPM with the same MRI-conditional value proposition.
• Schiller AG: Schiller is a privately held Swiss-German medtech company with a strong focus on patient monitoring and defibrillation, including MRI-compatible offerings. Its portfolio overlap in MRI-safe patient monitors and defibrillators makes it a direct specialty competitor to MIPM's Tesla and TOF lines.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/MipmMammendorferInstitutFurPhysikUndMedizinGmbh

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mammendorfer Institut für Physik und Medizin